201 results on '"Buño, I."'
Search Results
2. EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
3. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML
4. Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience
5. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins
6. UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation
7. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
8. Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells
9. Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT
10. A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT
11. CYCLOSPORINE IN COMBINATION WITH 3 VERSUS 4 DOSES OF METHOTREXATE FOR GRAFT VERSUS HOST DISEASE PROPHYLAXIS AFTER HLA-MATCHED ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA PATIENTS: PH-AB240
12. HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO-HSCT) WITH HIGH DOSE CYLOPHOSPHAMIDE POST-TRANSPLANT (PT-CY) AS GVHD PROPHYLAXIS IN HIGH RISK HEMATOLOGIC MALIGNANCIES: MULTICENTRIC SPANISH EXPERIENCE: PH-P377
13. INFLUENCE OF KIR GENOTYPE ON SURVIVAL IN THE SETTING OF DUAL STEM CELL TRANSPLANTATION: PH-P076
14. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms
15. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect
16. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms
17. Autologous stem cell transplantation in patients with acute myeloid leukaemia: results after long follow-up: P954
18. Dynamics of chimerism in activated leukocytes (CD25+) improves anticipation of acute GvHD after HLA-identical related allogeneic stem cell transplantation: P740
19. Mesenteric inflammatory veno-occlusive disease (MIVOD) after allogeneic peripheral blood stem cell transplantation (PBSCT)
20. Heterogeneous loss of the Y chromosome in leukocyte lineages of donor origin after stem cell transplantation
21. Reasons for which some stem cell transplant candidates are not finally transplanted. The experience of two Spanish SCT teams using an electronic tool to manage the SCT schedule
22. Successful treatment of graft rejection with immunosuppression withdrawal and/or donor leukocyte infusion after early diagnosis based on T-cell mixed chimerism
23. Cyclophosphamide + GCSF as mobilising schedule in multiple myeloma and malignant lymphoma patients: factors associated with mobilisation efficiency
24. The dynamics of chimerism evolution determines the differential outcome of various transplant settings
25. Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative
26. Heterogeneous loss of the Y chromosome in leukocyte lineages after SCT from a non-HLA-identical family donor
27. Efficacy of autologous stem cell transplant in aids-related lymphoma patients
28. Sau3A in situ digestion of human chromosome 3 pericentromeric heterochromatin. I. Differential digestion of α-satellite and satellite 1 DNA sequences
29. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma
30. Fluorescence In Situ Hybridization Evaluation of Minimal Residual Disease on Stem-Cell Harvests
31. Chimerism Quantification after Sex-Matched BMT: How Probable Is It to Find Donor/Recipient Pairs with Distinguishable Cells?
32. Erratum: Quantification of donor and recipient hemopoietic cells by real-time PCR of single-nucleotide polymorphisms
33. Personalized monitoring of circulating tumor DNA by a specific signature of trackable mutations after chimeric antigen receptor t‐cell therapy in non‐Hodgkin B cell lymphoma.
34. ANALYSIS OF EZH2 MUTATIONS IN SOLID AND LIQUID BIOPSY AND ITS ROLE AS PREDICTIVE BIOMARKER FOR CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA.
35. 65c - Donor Cell MDS with Rare Complex Karyotype After Mismatch Alobmt for Ph+ALL
36. 181 - SF3B1 Mutation in Low-Risk MDS: Impact of its Incorporation to the Updated 2016 Who Classification and Relationship with Ferric Overload
37. PB2161: CHARACTERISTICS OF AGGRESSIVE B‐CELL LYMPHOMAS WITH MYC REARRANGEMENT.
38. P1427: MONITORING CAR‐T CELL IN B‐CELL LYMPHOMA PATIENTS THROUGH SINGLE CHAIN VARIABLE FRAGMENT BY DIGITAL PCR.
39. P1423: CIRCULATING CELL‐FREE DNA KINETICS MEASURED BY DIGITAL PCR IN LYMPHOMA PATIENTS UNDERGOING CD19‐CAR‐T THERAPY.
40. P391: FLT3‐ITD MEASUREMENT AT DIAGNOSIS AND FOR THE ASSESSMENT OF MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: CDNA VS. DNA.
41. RELAPSE CHARACTERIZATION IN DIFFUSE LARGE B CELL LYMPHOMA PATIENTS UNDERGOING COMMERCIAL CAR‐T CELL THERAPY: EXPERIENCE FROM A SINGLE CENTRE.
42. Iv Busulfan Based Conditioning Regimen for Haploidentical Transplantation
43. Alul in situ digestion of human alphoid and classical satellite DNA regions: High-resolution digital image analysis of FISH signals from condensed and extended chromatin.
44. 475: Why are some Stem Cell Transplant Candidates (SCT) not Finally Transplanted? the Experience of a SCT Team using an Electronic Tool to Manage the Transplant Schedule
45. Listeria monocytogenes meningitis in two allogeneic hematopoietic stem cell transplant recipients.
46. Clinical usefulness of the electronic management of the stem cell transplant schedule: Clinical evolution of candidate patients
47. Why are some Stem Cell Transplant Candidates (SCT) not Finally Transplanted? the Experience of a SCT Team using an Electronic Tool to Manage the Transplant Schedule
48. Quantification of donor and recipient hemopoietic cells by real-time PCR of single-nucleotide polymorphisms.
49. The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation
50. Novel Fibroblast Growth Factor Receptor 3-Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.